(19)
(11) EP 1 374 873 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.06.2005 Bulletin 2005/26

(45) Mention of the grant of the patent:
27.04.2005 Bulletin 2005/17

(21) Application number: 02703474.3

(22) Date of filing: 28.02.2002
(51) International Patent Classification (IPC)7: A61K 31/7008, A61P 35/00
(86) International application number:
PCT/CN2002/000119
(87) International publication number:
WO 2002/067946 (06.09.2002 Gazette 2002/36)

(54)

THE USE OF N-ACETYL-D-GLUCOSAMINE IN THE MANUFACTURE OF PHARMACEUTICAL USEFUL FOR SUPRESSING SIDE-EFFECT OF RADIOTHERAPY AND CHEMOTHERAPY

VERWENDUNG VON N-ACETYL-D-GLUCOSAMIN BEI DER HERSTELLUNG EINES ARZNEIMITTELS ZUR UNTERDRÜCKUNG DER NEBENWIRKUNGEN VON STRAHLENTHERAPIE UND CHEMOTHERAPIE

UTILISATION DE LA N-ACETYL-D-GLUCOSAMINE DANS LA PREPARATION DE COMPOSITIONS PHARMACEUTIQUES UTILISEES DANS LA SUPPRESSION DES EFFETS SECONDAIRES CAUSES PAR LA RADIOTHERAPIE ET LA CHIMIOTHERAPIE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.02.2001 CN 01104882

(43) Date of publication of application:
02.01.2004 Bulletin 2004/01

(73) Proprietors:
  • Third Military Medical University Chinese People's Liberation Army P.R. of China
    Chongqing 400038 (CN)
  • Bio-Wave Institute of Suzhou Hi-Tech New District Corporation, Ltd
    Jiangsu 215011 (CN)
  • Beijing Sino-Hongkong Dafu Science & Technology of Biowave Co., Ltd.
    Beijing 101200 (CN)

(72) Inventors:
  • XU, Qiwang
    Chongqing 400038 (CN)
  • LIU, Junkang
    Chongqing 400038 (CN)
  • YUAN, Zetao
    Chongqing 400038 (CN)

(74) Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät 
Maximilianstrasse 58
80538 München
80538 München (DE)


(56) References cited: : 
WO-A-93/14765
CN-A- 1 156 026
CN-A- 1 156 028
 WO-A-93/18775
CN-A- 1 156 027
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).